バイオ医薬品分析試験サービス市場規模、シェア、成長分析、分子タイプ別、試験タイプ別、ワークフロー別、用途別、エンドユーザー別、地域別 - 業界予測、2024～2031年

バイオ医薬品分析試験サービスの世界市場規模は、2022年に29億米ドルと評価され、2023年の33億5,000万米ドルから2031年には106億9,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは15.6％で成長する見通しです。

バイオ医薬品分野では、医薬品開発の成功は、高度な分析手法に支えられたタンパク質と化合物の正確な分類にかかっています。これらの技術は、バイオ医薬品の構造と機能性を理解するために不可欠であり、医薬品候補の選択からプロセスの最適化までの各段階に情報を提供します。進化する研究開発の状況に応じて、多様な分析ツールに対する需要が急増しています。COVID-19の大流行により、北米での分析試験サービスは当初閉鎖され支障をきたしていましたが、徐々に規制が解除され、ラボの運営は活気を取り戻しています。ライフサイエンス・サービスの再開に伴い、バイオ医薬品分析試験サービスに対する需要の増加が予想され、予測期間を通じて同地域の市場成長を後押ししています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• 特許分析

バイオ医薬品分析試験サービス市場規模：分子タイプ別およびCAGR（2024～2031年）

• 市場概要
• 小分子
• 巨大分子

バイオ医薬品分析試験サービス市場規模：試験タイプ別およびCAGR（2024～2031年）

• 市場概要
• ADME（吸収分布代謝排泄）
• 薬物動態（PK）
• 薬力学（PD）
• バイオアベイラビリティ
• 生物学的同等性
• その他

バイオ医薬品分析試験サービス市場規模：ワークフロー別およびCAGR（2024～2031年）

• 市場概要
• サンプル調製
• サンプル分析

バイオ医薬品分析試験サービス市場規模：用途別およびCAGR（2024～2031年）

• 市場概要
• 腫瘍学
• 神経学
• 心臓病学
• 感染症
• その他

バイオ医薬品分析試験サービス市場規模：エンドユーザー別およびCAGR（2024～2031年）

• 市場概要
• 製薬・バイオテクノロジー企業
• 契約調査機関（CRO）
• 学術研究機関
• その他

バイオ医薬品分析試験サービス市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Eurofins Scientific
• Charles River Laboratories
• WuXi AppTec
• SGS SA
• Laboratory Corporation of America Holdings（LabCorp）
• IQVIA
• Medpace
• Intertek Group
• Syneos Health
• ICON plc
• Frontage Laboratories
• PPD（Pharmaceutical Product Development）
• PAREXEL International
• Almac Group
• Celerion
• Altasciences
• BioAgilytix Labs
• Lotus Labs
• LGS Limited
• Sartorius AG

結論と推奨事項

Global Biopharmaceutical Analytical Testing Services Market size was valued at USD 2.90 billion in 2022 and is poised to grow from USD 3.35 billion in 2023 to USD 10.69 billion by 2031, growing at a CAGR of 15.6% during the forecast period (2024-2031).

In the biopharmaceutical sector, successful drug development hinges on the precise classification of proteins and compounds, supported by advanced analytical methods. These technologies are essential for comprehending the structure and functionality of biotherapeutics, informing every stage from drug candidate selection to process optimization. The demand for diverse analytical tools is surging in response to the evolving R&D landscape. Although the COVID-19 pandemic initially hindered analytical testing services in North America due to lockdowns, the gradual lifting of restrictions has rejuvenated laboratory operations. As life sciences services resume, there is an anticipated increase in demand for biopharmaceutical analytical testing services, propelling market growth in the region throughout the forecasted period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceutical Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceutical Analytical Testing Services Market Segmental Analysis

Global Biopharmaceutical Analytical Testing Services Market is segmented by molecule type, test type, workflow, application, end user and region. Based on molecule type, the market is segmented into small molecule and large molecule. Based on test type, the market is segmented into ADME (absorption, distribution, metabolism, and excretion), pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, bioequivalence and others. Based on workflow, the market is segmented into sample preparation and sample analysis. Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases and others. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceutical Analytical Testing Services Market

A significant driver of growth in the global biopharmaceutical analytical testing services market is the escalating demand for Methyl Methacrylate Acrylonitrile Butadiene Styrene, primarily used in immunotherapy to enhance immune responses against various diseases. Research and development initiatives focused on antibodies for conditions such as rheumatoid arthritis and cancer are expanding. Targeted treatments for cancer involve specific localization to improve efficacy. Additionally, the rising preference for customized medicine is boosting the need for monoclonal antibodies, prompting pharmaceutical and biotechnology companies to manufacture Ethyl Methacrylate Acrylonitrile. Consequently, these products undergo rigorous quality control processes, including microbial, sterility, and dissolution testing, to ensure drug integrity, which subsequently fuels the demand for biopharmaceutical analytical testing services that provide critical impurity data, characterization, and validation.

Restraints in the Global Biopharmaceutical Analytical Testing Services Market

Global Biopharmaceutical Analytical Testing Services face several restraints that can impact their operations and growth. Stringent regulatory requirements necessitate rigorous compliance, potentially delaying product testing and market entry. The rapidly evolving technological landscape demands continuous investment in advanced analytical methods, which can strain financial resources. Additionally, the shortage of skilled professionals in the biopharmaceutical field can hinder the capacity to meet increasing demand for testing services. Competition among service providers leads to price pressures, while the complexity of biologics requires specialized expertise that may not be universally available, limiting the ability to scale operations efficiently within a global framework.

Market Trends of the Global Biopharmaceutical Analytical Testing Services Market

The Global Biopharmaceutical Analytical Testing Services market is witnessing a significant upward trend, fueled by heightened investments in research and development (R&D). With R&D expenditures surging by 3.21% in 2021, the focus on enhancing analytical testing capabilities is set to intensify. Emerging economies are outpacing their developed counterparts, showcasing robust growth through the establishment of new laboratories and research facilities. This shift not only fosters innovation but also enhances the overall capacity for biopharmaceutical testing, meeting the increasing demand for high-quality and efficient biotherapeutic solutions. As a result, the market is poised for substantial expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Molecule Type & CAGR (2024-2031)

• Market Overview
• Small Molecule
• Large Molecule

Global Biopharmaceutical Analytical Testing Services Market Size by Test Type & CAGR (2024-2031)

• Market Overview
• ADME (Absorption, Distribution, Metabolism, and Excretion)
• Pharmacokinetics (PK)
• Pharmacodynamics (PD)
• Bioavailability
• Bioequivalence
• Others

Global Biopharmaceutical Analytical Testing Services Market Size by Workflow & CAGR (2024-2031)

• Market Overview
• Sample Preparation
• Sample Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Application & CAGR (2024-2031)

• Market Overview
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Others

Global Biopharmaceutical Analytical Testing Services Market Size by End User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Others

Global Biopharmaceutical Analytical Testing Services Market Size & CAGR (2024-2031)

• North America (Molecule Type, Test Type, Workflow, Application, End User)
  • US
  • Canada
• Europe (Molecule Type, Test Type, Workflow, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Molecule Type, Test Type, Workflow, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Molecule Type, Test Type, Workflow, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule Type, Test Type, Workflow, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD (Pharmaceutical Product Development)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altasciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lotus Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGS Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation